Scott N. Holden

机构：St. Thomas Hospital

发表论文 46 篇 · 总被引 4724 次 · h-index 25

代表论文

• Arterial Thromboembolic Events in Patients with Metastatic Carcinoma Treated with Chemotherapy and Bevacizumab (2007 · JNCI Journal of the National Cancer Institute · 被引 937)
• Phase I Study of Trastuzumab-DM1, an HER2 Antibody-Drug Conjugate, Given Every 3 Weeks to Patients With HER2-Positive Metastatic Breast Cancer (2010 · Journal of Clinical Oncology · 被引 600)
• Impact of Vascular Endothelial Growth Factor-A Expression, Thrombospondin-2 Expression, and Microvessel Density on the Treatment Effect of Bevacizumab in Metastatic Colorectal Cancer (2005 · Journal of Clinical Oncology · 被引 389)
• Drug Absorption Interactions Between Oral Targeted Anticancer Agents and PPIs: Is pH-Dependent Solubility the Achilles Heel of Targeted Therapy? (2012 · Clinical Pharmacology & Therapeutics · 被引 337)
• Association of k-ras, b-raf, and p53 Status With the Treatment Effect of Bevacizumab (2005 · JNCI Journal of the National Cancer Institute · 被引 323)
• Clinical evaluation of ZD6474, an orally active inhibitor of VEGF and EGF receptor signaling, in patients with solid, malignant tumors (2005 · Annals of Oncology · 被引 308)